CORNERSTONE THERAPEUTICS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-06-21: Reporting owner Chiesi Farmaceutici SpA; Form 4; Security 6.5% Convertible Term Loan due June 21, 2014; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-06-21 | Chiesi Farmaceutici SpA 10% Owner | 4 | 6.5% Convertible Term Loan due June 21, 2014 Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | 4,226,542 owned after | $7.10 exercise price | 2012-06-25 |